Nivalin

Sopharma is a leading Bulgarian pharmaceutical company specializing in the development, production, and distribution of branded and generic medicines. Founded in 1933, the company is globally recognized for its expertise in phytopharmaceuticals, particularly its flagship product Nivalin (galantamine), which was originally developed for poliomyelitis and is now widely used for Alzheimer's disease. Sopharma operates a vertically integrated business model with 14 manufacturing plants across Bulgaria, Ukraine, and Serbia, producing over 200 products in various therapeutic areas including neurology, cardiology, and gastroenterology. The company also provides contract manufacturing services and maintains a significant distribution network through its subsidiary, Sopharma Trading.